| Literature DB >> 32699252 |
Hsuan-Te Chu1,2, Chih-Sung Liang1,3, Ta-Chuan Yeh4, Li-Yu Hu5,6, Albert C Yang2,6,7, Shih-Jen Tsai8,9,10, Cheng-Che Shen11,12.
Abstract
Tinnitus has been implied as a "soft" sign of neurodegenerative disease, which is characterized by progressive loss of neuronal function, such as Alzheimer's disease (AD) and Parkinson's disease (PD). This study aimed to determine whether the risk of developing AD/PD increases after having tinnitus. We conducted a retrospective matched cohort study with 12,657 tinnitus patients and 25,314 controls from the National Health Insurance Research Database (NHIRD) in Taiwan with almost 10 years follow-up. Tinnitus-related risk on developing AD/PD followingly was determined by the Cox regression to identify potential confounding factors. Through the 10-year follow-up period, 398 individuals with tinnitus (3.1%) and 501 control individuals (2.0%) developed AD (P < 0.001), and 211 tinnitus patients (1.7%) and 249 control patients (1.0%) developed PD (P < 0.001). Compared with controls, patients with tinnitus were 1.54 times more likely to develop AD (95% confidence interval (CI) 1.34-1.78, P < 0.001) and 1.56 times more likely to develop PD (95% CI 1.29-1.89, P < 0.001), after adjusting confounding factors. Our results indicate an association between tinnitus and higher risk of developing AD and PD. Additional physical comorbidities may also increase the risk of developing AD and PD.Entities:
Mesh:
Year: 2020 PMID: 32699252 PMCID: PMC7376045 DOI: 10.1038/s41598-020-69243-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline characteristics of patients with and without tinnitus.
| Demographic data | Patients with tinnitus | Patients without tinnitus | |||
|---|---|---|---|---|---|
| % | % | ||||
| 52 (41–64) | 52 (41–64) | 0.982 | |||
| ≥ 60 | 8,352 | 66.0 | 16,704 | 66.0 | |
| < 60 | 4,305 | 34.0 | 8,610 | 34.0 | |
| 0.999 | |||||
| Male | 6,028 | 47.6 | 12,056 | 47.6 | |
| Female | 6,629 | 52.4 | 13,258 | 52.4 | |
| Hypertension | 4,047 | 32.0 | 6,530 | 25.8 | < 0.001* |
| Diabetes mellitus | 2,219 | 17.5 | 3,453 | 13.6 | < 0.001* |
| Coronary artery disease | 179 | 1.4 | 299 | 1.2 | 0.055 |
| Congestive heart failure | 523 | 4.1 | 756 | 3.0 | < 0.001* |
| Chronic lung disease | 2,389 | 18.9 | 3,492 | 13.8 | < 0.001* |
| Malignant neoplasms | 283 | 2.2 | 395 | 1.6 | < 0.001* |
| Head injury | 2030 | 16.0 | 3,158 | 12.5 | < 0.001* |
| Cerebrovascular disease | 983 | 7.8 | 1,357 | 5.4 | < 0.001* |
| Osteoarthritis | 3,448 | 27.2 | 4,799 | 19.0 | < 0.001* |
| Rheumatologic disease | 1,134 | 9.0 | 1,422 | 5.6 | < .001* |
| 0.227 | |||||
| Urban | 7,374 | 58.3 | 14,940 | 59.0 | |
| Suburban | 3,974 | 31.4 | 7,697 | 30.4 | |
| Rural | 1,309 | 10.3 | 2,677 | 10.6 | |
| < 0.001* | |||||
| Low income | 6,089 | 48.1 | 13,002 | 51.4 | |
| Medium income | 4,898 | 38.7 | 9,343 | 36.9 | |
| High income | 1,670 | 13.2 | 2,969 | 11.7 | |
| 7.42 (6.09–8.71) | 7.40 (6.07–8.70) | 0.094 | |||
| 398 | 3.1 | 501 | 2.0 | < 0.001* | |
| 211 | 1.7 | 249 | 1.0 | < 0.001* | |
aIndicates median (interquartile range); AD indicates Alzheimer disease; PD indicates Parkinson disease.
*Indicates statistical significance.
Associations between tinnitus with risk of Alzheimer’s disease and Parkinson’s disease.
| Alzheimer’s disease | Parkinson’s disease | |||
|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | |||
| Model I | 1.62 (1.41–1.85) | < 0.001 | 1.69 (1.41–2.04) | < 0.001 |
| Model II | 1.54 (1.34–1.78) | < 0.001 | 1.56 (1.29–1.89) | < 0.001 |
| Model III | 1.34 (1.17–1.53) | < 0.001 | 1.44 (1.19–1.73) | < 0.001 |
Model I: univariate analysis.
Model II: included univariate analysis factors with a moderate statistically significant relationship (i.e., P < 0.1) into a multivariate Cox proportional-hazards regression model by using the forward selection method.
Model III: included all variates.
Figure 1Cumulative incidence of Alzheimer's disease estimated for tinnitus group (solid line) and control group (dashed line).
Figure 2Cumulative incidence of Parkinson's disease estimated for tinnitus group (solid line) and control group (dashed line).